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The initial cases of pulmonary infection with the novel coro-
na virus SARS-CoV-2, causing COVID-19, occurred in Wuhan, 
Hubei Province, China in December 2019 and January 2020 (1). 
The spread through human-to-human transmission has led to 
a pandemic with disastrous consequences all over the world. 
The exponential rate of transmission and no existing vaccine 
has been a great challenge for all health care systems. A strat-
egy to flatten the curve of transmission was put forward to 
adjust to the capacities of hospitals and particularly the inten-
sive care units. Governments implemented isolation and social 
distancing upon societies either with laws or with strong rec-
ommendations. 
As the pandemic proceeds anecdotal reports indicate that vi-
rus particles reside with extremely high concentrations in the 
nasal cavity and nasopharynx. Surgery involving respiratory 
epithelium is suddenly considered a significant risk factor for 
transmission (2). Evolving knowledge and experiences from 
China, Italy and Iran demonstrate that ENT (Ear, Nose and 
Throat) surgeons are amongst the highest risk professionals 
for contaminating themselves during their daily work.
Transmission is most probably via droplets from mucus or 
aerosolized particles when examining or operating in areas with 
contaminated epithelium and mucosae. In a sense middle ear 
mucosae and even the mastoid can be considered as part of 
the upper airway in terms of histological epithelium. Corona vi-
ruses have been detected in otitis media already in 1998 (3, 4). 
However, little is known about the behaviour of the new SARS-
CoV-2 virus in the middle ear.  Extra precautions seem nec-
essary during otological surgery to prevent viral transmission, 
especially when high-speed drills are used together with irri-
gation. If a mastoid contains Sars-CoV-2 viral particles, classic 
mastoidectomy with a drill presents a great danger for aerosol-
izing particles in the operating theatre. At this moment of the 
COVID-19 pandemic there is a general belief that every health 
care worker in the operation theatre during mastoidectomy 
would be at risk. 
Currently, many countries have issued local restrictions for 
the community with significant differences across the world. 
Correspondingly, many hospitals have local guidelines that 
are based on local resources and evolving insights. A guideline 
is by definition bound to a timeline and it seems during the 
COVID-19 pandemic these can change on a daily basis. As long 
as the supply of COVID-19 screening tests cannot meet the 
rising demand for testing or the interval between performing 
the swab and getting the result, the COVID-19 status of emer-
gency cases may remain unknown. It seems obvious when 
there is no time or no capacity to test an emergency patient to 
consider these cases COVID-19 positive in both the outpatient 
clinic and the operation theatre. 
This commentary aims to raise awareness amongst otolar-
yngologists in a difficult situation when confronted with pa-
tients that seem to require an “ontological” intervention. The 
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authors do not claim to give guidelines and this manuscript is 
not intended for legal disputes. Most probably the listed pos-
sible scenarios are not even complete. However, clinical con-
siderations and precautions are discussed for otological emer-
gencies to help a clinician decide in difficult situations. The 
COVID-19 pandemic is not a time for medicine according to 
protocol but rather medicine according to reasoning.
Fortunately, acute life-threatening ear diseases requiring im-
mediate surgery or even within 24 hours are infrequent. This 
is probably also the advantage of easy accessible health care 
systems in their normal functioning. Otological pathology is 
usually detected earlier and most often before it can lead to 
life threatening situations. During the COVID-19 pandemic 
there is a danger that patient with mild symptoms stay home 
and as the contamination risk continues over time, we could 
face more advanced otologic disease in emergency settings. 
Nevertheless, acute life-threatening complications of middle 
ear disease occur occasionally. Moreover, a classic mastoidec-
tomy using a high-speed drill is a rather common procedure 
to gain access to the mastoid for several surgical treatments. 
In these cases, when there is no time to wait for COVID-19 
screening test results, the patient should be considered po-
tentially COVID-19 positive and the necessary procedure is 
performed under the best protective precautions given by the 
local hospital resources and guidelines. Even if the COVID-19 
status is screened negative it might still be relevant to take 
precautions because of an alleged high false-negative rate. A 
larger study analysed a total of 1070 specimens of different 
types that were collected from 205 patients with COVID-19. 
(5) Bronchoalveolar lavage fluid specimens showed the highest 
positive rates (14 of 15; 93%), followed by sputum (72 of 104; 
72%), nasal swabs (5 of 8; 63%), fibro bronchoscope brush 
biopsy (6 of 13; 46%), pharyngeal swabs (126 of 398; 32%), 
faeces (44 of 153; 29%), and blood (3 of 307; 1%). Usually, 
emergency imaging is performed of the temporal bone and a 
consideration could be to have a limited dose-screening CT-
scan of the thorax simultaneously. There have been reports 
that pulmonary COVID-19 lesions are easily recognized even 
in asymptomatic patients and are perhaps more sensitive than 
PCR screening tests (6). Although the surgeon is going to take 
COVID-19 precautions anyhow, this CT thorax could be of 
added value to the anaesthesiologist for the ventilation of the 
patient during the surgery. Experienced surgeons should best 
perform these procedures in absence of residents in training 
or interns to reduce surgical time and not to run the risk that 
an observing resident would be contaminated. In that sense no 
observers are allowed in theatre and the surgical team is best 
reduced to experienced staff in terms of anaesthesiologist, 
scrub nurse, circulating nurse and surgeon. All of them work 
under strict COVID-19 precautions as given by local hospital 
policies or guidelines of international professional societies or 
World Health Organization (WHO). The team should also pay 
attention to a strictly limited number of door movements and 
hazardous entries of unnecessary visitor/personnel in the the-
atre. Markings on the doors with “COVID-19 contaminated” 
are necessary precautions to warn personnel.
The surgeon should actively evaluate why and if the use of a 
high-speed drill is needed. The use of the high-speed drill is 
inevitably related with significant aerosolisation of bone and 
other tissues during drilling (7). Although transmission of vi-
ral particles is mainly through the respiratory system, there is 
some evidence of blood-borne transmission (8, 9). As experi-
enced surgeons are used to treat HIV positive patients this risk 
is low, but present.  Adequate hypotension facilitated by the 
anaesthesiologist will reduce bleeding tendency and reduce 
the related aerosolisation of blood and other mastoid fluids. An 
alternative could be the use of a piezoelectric drill, although 
the possible aerosolisation with such a device has never been 
quantified (10).
If possible, a chisel combined with curettes should be used for 
instance to facilitate drainage in acute mastoiditis instead of 
the drill. The infection often has weakened the bony cortex and 
once beyond tabula externa of the cortex the diploe is easily 
managed with curettes. FFP3 masks (with protective goggles or 
face-shield), or in case of limited resources FFP2, are advised by 
local protocols during surgery for the whole surgical team. The 
surgeon should consider wearing a face-shield because standard 
eye protection may not adequately prevent ocular transmission 
when the mastoidectomy is performed without microscope. 
Transmission through tears is perhaps not likely but there have 
been reports that speculate presence of Corona viruses in tears 
(11). When the use of the microscope is necessary the surgeon 
should not have a false sense of safety behind the microscope. 
The use of a face shield may be difficult behind the microscope, 
but perhaps customized self-made protection shields on the 
outer surface of the sterile microscope dress could be created. 
The use of exoscope, when available, should be considered. Even 
endoscopes may have an extra advantage nowadays for placing 
grommets or to perform paracentesis.
Table 1 summarizes a possible timeline for ear diseases re-
quiring surgical intervention. Most of the treatments for these 
ear diseases have regional protocols and guidelines that might 
even differ between different otologic schools. As mentioned 
before, our aim was to generate awareness and advocate pre-
cautions. This table is best interpreted as a consideration at 
this stage of the COVID-19 pandemic and perhaps more spe-
cifically the stage the pandemic is in Belgium in April 2020. It 
is very likely that these timelines will shift within a month or 
two because COVID-19 will not leave after a month. After the 
peak of this pandemic, restrictions on daily otological practice 
should somehow be adjusted to allow health service closer to 
the standards we are used to (Table 1).
The relatively most frequent otological emergency that comes 
to mind is complicated acute otitis media. If mastoiditis is diag-
nosed by radiological imaging and the patient is stable and free 
from underlying condition that potentially compromises normal 
recovery, a medical therapy seems safe to be offered in the first 
24 to 48 hours. Admission to the hospital with appropriate in-
travenous (IV) antibiotics is advisable and otorrhea is favoured 
to speed up evacuation. Introduction of a grommet is advised in 
many guidelines at this stage. However, when this would require 
general anaesthesia for instance in a paediatric patient there 
would be a risk for contamination. The risk of this contamination 
probably does not justify the possibly little benefit of the grom-
met to this patient. The main benefit will have to come from 
the IV antibiotics at this stage of the mastoiditis. A paracentesis 
under local anaesthesia could be considered as an alternative. 
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When a mastoiditis is also complicated with a subperiostal ab-
scess surgery seems necessary within 48-72 hours. If there are 
clinical signs of sepsis the surgery should be offered even fast-
er, especially when a sepsis is present this surgery becomes an 
emergency. Basically, this example of acute mastoiditis demon-
strates how table 1 should be interpreted: with reasoning and 
not blindly as a protocol. Many otological diseases can be safely 
deferred depending on the clinical presentation of the patient 
but much also depends on the comfort zone of the responsi-
ble surgeon. The treating surgeon is best suited to evaluate the 
treats of illness itself and the patient characteristics (including 
age, predisposing conditions, etc.) and weight this carefully to 
the risk of contamination the whole operation team. Main goals 
would be a safe working environment for health care workers 
and appropriate care for the patient.
Admission of a patient to hospital either for surgery or not, 
requires of course that hospital management provides clean 
areas for these patients and defines contaminated areas for 
COVID-19 positive patients and clean areas for COVID-19 
negative patients. But still there are movements of patients 
requiring extra examinations and personnel are moving around 
as well. Elective interventions are therefore contra-indicated. 
This is not new in otology. When a patient is diagnosed with 
pneumonia all elective ear surgery is usually deferred. In case 
of a false negative COVID-19 test the mechanical ventilation 
during the surgery can worsen the COVID-19 status of a patient 
to a more severe stage. The COVID-19 infection is described as 
a 3-stage process: stage I, an asymptomatic incubation period 
with or without detectable virus; stage II, non-severe symp-
tomatic period with the presence of virus; stage III, severe re-
spiratory symptomatic stage with high viral load (12). Even the 
high risk of contamination of all otologic patient in a post-op-
erative period by just being in the hospital makes it necessary 
to evaluate on a “day by day” basis and weigh the decision to 
indicate which procedure is really a vital emergency. Therefore 
table 1 should be interpreted in the specific scenario of each 
hospital with their specific precautions and capacities and in 
light of the local epidemiological stage as well.
Although table 1 is focussed on surgical interventions otologist 
might encounter some challenges in otological emergencies 
usually treated in an outpatient setting. For instance, there is a 
large consensus on the use of early oral steroid therapy for sud-
den sensorineural hearing loss (SNHL). This might require us to 
discuss this therapy with infectious disease specialist whether 
the COVID-19 status of the patient will allow this or not. The 
same will perhaps apply for idiopathic facial nerve palsy. Despite 
consensus on the use of early steroid therapy for idiopathic fa-
cial nerve palsy, the Covid-19 pandemic entails a general ten-
dency not to start oral steroids until safety data is available. 
Most outpatient activities are postponed for the moment for 
most ENT services except for head and neck oncology pro-
grams perhaps. However, sometimes there might be a risk for 
overlooking a potentially life-threatening disorder, e.g. when 
acute-onset vertigo is produced by a stroke in the posterior 
fossa and not by self-limiting vestibular neuritis. Hopefully the 
current restrictive measures will flatten the curve soon and 
otorhinolaryngologists can gradually resume daily practice.
Many disturbing reports have put otorhinolaryngologists 
amongst the clinicians most at risk of COVID-19 infection. At 
this moment we don’t know why. Is it because ENT surgeons 
have worked with COVID-19 patients in a non-routine environ-
ment: screening at emergency and patient care on wards. Could 
it be that we contaminate ourselves because of non-routine 
tasks? Or, is it perhaps because of our previous routine tasks? 
More specifically an otorhinolaryngologist in a routine workflow 
in the outpatient clinic or even operating theatre will work with 
the upper airway. It seems likely that ENT surgeons have had 
exposure to several corona virus infections before in their career. 
Could it be that this makes us more prone to an extreme overre-
action of the immune system by this new COVID-19 virus? 
Probably these questions will be answered by ongoing or fu-
ture studies. Meanwhile, table 1 is based upon the assumption 
that our routine work-related transmission risk is high. With 
progressing insight this table might even be obsolete tomor-
row. For the time being, it gives some cohesion among otolo-
gists for helping our patient and protecting our team.
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Table 1. Priority of otologic surgery during Covid-19 
pandemic 
Priority: As Soon As Possible (ASAP)
• Life threatening compllications of ear disease
Priority: Within 48 to 72 hours
• Acute mastoiditis not responding to intravenous antibiotics
• Acute mastoiditis with subperiosteal abscess
• Cholesteatoma with facial nerve palsy
• Cholesteatoma with intracranial complication
• Barotrauma with evident perilymph fistula and SNHL
• Trauma to
Facial nerve
Pinna
• Hydrocephalus because of brainstem compression by 
vestibular schwannoma
Priority: Delay up to 4 weeks may seem safe for
• Cochlear implantation for SNHL because of meningitis
• Otologic Neoplasia; shared decision of multidisciplinary 
teams
Priority: Delay up to 12 weeks may seems safe for
• Cholesteatoma, uncomplicated and stable
• Cochlear implantation for pre-lingual profound SNHL
• Implantable hearing aids
• Non-life threatening lesions requiring neurotologic 
procedures
• Ossiculoplasty, Stapedoplasty, Meatoplasty, Tympanoplasty
• Grommets
March 2020 Belgium; SNHL: sensorineural hearing loss
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